Jan
Skin Cancer Linked to Increased Risk More Serious Cancers
Non-melanoma skin cancer, formally known as basal cell or squamous cell carcinoma, is the most commonly developed skin cancer affecting 1 million people in the United States each year. It is often easily detected and, when treated properly, has a cure rate of 95 percent, according to the American Academy of Dermatology. This type of cancer rarely spreads to other parts of the body, but it can extend below the skin to the bone and cause considerable local damage. Doctors already know that non-melanoma skin cancer places people at high risk for developing additional skin cancers, but new research indicates it may also increase the risk of developing other malignancies in the body.
A team of researchers led by Jiping Chen, M.D., Ph.D., of the National Cancer Institute and Anthony Alberg, Ph.D., MPH, associate director for cancer prevention and control at the Hollings Cancer Center of the Medical University of South Carolina in Charleston looked at the data from a 16-year study involving 19,174 residents in Washington County, Maryland; 769 with non-melanoma skin cancer and 18,405 who were cancer free. After measuring and comparing the cancer risk of the participants, they found that individuals aged 25 to 44 who suffered from non-melanoma skin cancer were 2.6 times more likely to develop other types of cancer later in life, compared to those who never experienced the disease. In addition, the younger a person developed non-melanoma skin cancer, the higher their risk of developing other cancers.
Among the cancers likely to be contracted, melanoma was the most common, with eight times the risk, but there was also an increased risk of developing lung, colorectal and breast cancers. Prostate cancer was also linked but the association was not statistically significant. “It seems like non-melanoma skin cancer, even though it is a non-fatal disease, may be a warning sign for increased risk of other, more serious cancers,” Dr. Alberg said
Researchers speculate that part of the reason for the increased risk is that some people have difficulty repairing DNA damage, which make them more susceptible to environmental irritants and more likely to develop cancer. Furthermore, patients who have survived non-melanoma skin cancer are visiting their doctors regularly for follow-ups and are therefore more likely to be diagnosed with other cancers. “A personal history of non-melanoma skin cancer may be more a part of personal health history than we thought before,” said Dr. Alberg.
Margaret Karagas, associate director of the Center for Environmental Health Sciences at Dartmouth Medical School, told ABC News that this study could provide a “useful model” for future cancer research, listing radiation and arsenic among the cancer-causing agents that were initially discovered because they caused skin cancers. “It is also important because in many parts of the world it appears to be one of the most rapidly increasing cancers,” she said.
Another study led by Jennifer Christian from the VA Medical Center and Brown University found that patients taking blood pressure-lowering drugs called angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) had a 39 percent lower risk of developing basal cell skin cancer and a 33 percent lower risk of developing squamous cell skin cancer. The researchers say it is unclear why these drugs lower the risk of skin cancer.
|
If you have trouble seeing the images below, click here. |
|
|
